Page last updated: 2024-10-16

5-hydroxytryptophan and Postgastrectomy Syndromes

5-hydroxytryptophan has been researched along with Postgastrectomy Syndromes in 1 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Postgastrectomy Syndromes: Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (DUMPING SYNDROME and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hudock, JJ1
Vanamee, P1
Lawrence, W1

Other Studies

1 other study available for 5-hydroxytryptophan and Postgastrectomy Syndromes

ArticleYear
The effect of methyl dopa upon pancreatic secretory response to intrajejunal hypertonic glucose solution.
    Surgery, 1966, Volume: 60, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Dogs; Glucose; Humans; Hypertonic Solutions; Methyldopa; Norepinephrin

1966